Cargando…

Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients

The risk for venous thromboembolism (VTE) in medical patients is high, but risk assessment is rarely performed because there is not yet a good method to identify candidates for prophylaxis. PURPOSE: To perform a systematic review about VTE risk factors (RFs) in hospitalized medical patients and gene...

Descripción completa

Detalles Bibliográficos
Autores principales: T Rocha, Ana, F Paiva, Edison, Lichtenstein, Arnaldo, Milani, Rodolfo, Cavalheiro-Filho, Cyrillo, H Maffei, Francisco
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291339/
https://www.ncbi.nlm.nih.gov/pubmed/17969384
_version_ 1782152449662910464
author T Rocha, Ana
F Paiva, Edison
Lichtenstein, Arnaldo
Milani, Rodolfo
Cavalheiro-Filho, Cyrillo
H Maffei, Francisco
author_facet T Rocha, Ana
F Paiva, Edison
Lichtenstein, Arnaldo
Milani, Rodolfo
Cavalheiro-Filho, Cyrillo
H Maffei, Francisco
author_sort T Rocha, Ana
collection PubMed
description The risk for venous thromboembolism (VTE) in medical patients is high, but risk assessment is rarely performed because there is not yet a good method to identify candidates for prophylaxis. PURPOSE: To perform a systematic review about VTE risk factors (RFs) in hospitalized medical patients and generate recommendations (RECs) for prophylaxis that can be implemented into practice. DATA SOURCES: A multidisciplinary group of experts from 12 Brazilian Medical Societies searched MEDLINE, Cochrane, and LILACS. STUDY SELECTION: Two experts independently classified the evidence for each RF by its scientific quality in a standardized manner. A risk-assessment algorithm was created based on the results of the review. DATA SYNTHESIS: Several VTE RFs have enough evidence to support RECs for prophylaxis in hospitalized medical patients (eg, increasing age, heart failure, and stroke). Other factors are considered adjuncts of risk (eg, varices, obesity, and infections). According to the algorithm, hospitalized medical patients ≥40 years-old with decreased mobility, and ≥1 RFs should receive chemoprophylaxis with heparin, provided they don’t have contraindications. High prophylactic doses of unfractionated heparin or low-molecular-weight-heparin must be administered and maintained for 6–14 days. CONCLUSIONS: A multidisciplinary group generated evidence-based RECs and an easy-to-use algorithm to facilitate VTE prophylaxis in medical patients.
format Text
id pubmed-2291339
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-22913392008-04-22 Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients T Rocha, Ana F Paiva, Edison Lichtenstein, Arnaldo Milani, Rodolfo Cavalheiro-Filho, Cyrillo H Maffei, Francisco Vasc Health Risk Manag Systematic Review The risk for venous thromboembolism (VTE) in medical patients is high, but risk assessment is rarely performed because there is not yet a good method to identify candidates for prophylaxis. PURPOSE: To perform a systematic review about VTE risk factors (RFs) in hospitalized medical patients and generate recommendations (RECs) for prophylaxis that can be implemented into practice. DATA SOURCES: A multidisciplinary group of experts from 12 Brazilian Medical Societies searched MEDLINE, Cochrane, and LILACS. STUDY SELECTION: Two experts independently classified the evidence for each RF by its scientific quality in a standardized manner. A risk-assessment algorithm was created based on the results of the review. DATA SYNTHESIS: Several VTE RFs have enough evidence to support RECs for prophylaxis in hospitalized medical patients (eg, increasing age, heart failure, and stroke). Other factors are considered adjuncts of risk (eg, varices, obesity, and infections). According to the algorithm, hospitalized medical patients ≥40 years-old with decreased mobility, and ≥1 RFs should receive chemoprophylaxis with heparin, provided they don’t have contraindications. High prophylactic doses of unfractionated heparin or low-molecular-weight-heparin must be administered and maintained for 6–14 days. CONCLUSIONS: A multidisciplinary group generated evidence-based RECs and an easy-to-use algorithm to facilitate VTE prophylaxis in medical patients. Dove Medical Press 2007-08 /pmc/articles/PMC2291339/ /pubmed/17969384 Text en © 2007 Rocha et al, publisher and licensee Dove Medical Press Ltd.
spellingShingle Systematic Review
T Rocha, Ana
F Paiva, Edison
Lichtenstein, Arnaldo
Milani, Rodolfo
Cavalheiro-Filho, Cyrillo
H Maffei, Francisco
Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients
title Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients
title_full Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients
title_fullStr Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients
title_full_unstemmed Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients
title_short Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients
title_sort risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291339/
https://www.ncbi.nlm.nih.gov/pubmed/17969384
work_keys_str_mv AT trochaana riskassessmentalgorithmandrecommendationsforvenousthromboembolismprophylaxisinmedicalpatients
AT fpaivaedison riskassessmentalgorithmandrecommendationsforvenousthromboembolismprophylaxisinmedicalpatients
AT lichtensteinarnaldo riskassessmentalgorithmandrecommendationsforvenousthromboembolismprophylaxisinmedicalpatients
AT milanirodolfo riskassessmentalgorithmandrecommendationsforvenousthromboembolismprophylaxisinmedicalpatients
AT cavalheirofilhocyrillo riskassessmentalgorithmandrecommendationsforvenousthromboembolismprophylaxisinmedicalpatients
AT hmaffeifrancisco riskassessmentalgorithmandrecommendationsforvenousthromboembolismprophylaxisinmedicalpatients